BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is a significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.
The Company’s flagship product is The NGAL Test, which has been designed to aid in the risk assessment of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality if not identified and treated early.
Tuborg Havnevej 15, 2900 Hellerup – Denmark
Line item in (dkk) | 01.01.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 | 01.10.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | N/A | 58,053,000.00 | 140,286,000.00 | 121,378,000.00 | 109,479,000.00 | 100,691,000.00 | 81,255,000.00 | 163,257,000.00 | 146,878,000.00 | 133,571,000.00 | 108,640,000.00 | 85,295,000.00 | 112,084,000.00 | 97,900,000.00 |
Noncurrent Assets | N/A | 16,721,000.00 | 15,506,000.00 | 15,182,000.00 | 14,185,000.00 | 18,218,000.00 | 17,058,000.00 | 16,659,000.00 | 16,194,000.00 | 15,667,000.00 | 7,212,000.00 | 6,436,000.00 | 5,832,000.00 | 10,710,000.00 |
Property Plant And Equipment | N/A | N/A | N/A | N/A | N/A | N/A | 1,925,000.00 | 2,161,000.00 | 1,999,000.00 | 1,828,000.00 | 1,586,000.00 | 1,427,000.00 | 1,245,000.00 | 1,075,000.00 |
Fixtures And Fittings | N/A | 2,407,000.00 | 2,448,000.00 | 2,407,000.00 | 2,366,000.00 | 2,109,000.00 | 1,925,000.00 | 2,161,000.00 | 1,999,000.00 | 1,828,000.00 | N/A | N/A | N/A | N/A |
Intangible Assets Other Than Goodwill | N/A | 1,059,000.00 | 1,152,000.00 | 1,291,000.00 | 1,307,000.00 | 1,179,000.00 | 1,049,000.00 | 1,021,000.00 | 921,000.00 | 844,000.00 | 766,000.00 | 689,000.00 | 612,000.00 | 535,000.00 |
Current Tax Assets Noncurrent | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5,500,000.00 | 0.00 | N/A | N/A | 5,500,000.00 |
Current Assets | N/A | 41,332,000.00 | 124,780,000.00 | 106,196,000.00 | 95,294,000.00 | 82,473,000.00 | 64,197,000.00 | 146,598,000.00 | 130,684,000.00 | 117,904,000.00 | 101,428,000.00 | 78,859,000.00 | 106,252,000.00 | 87,190,000.00 |
Inventories | N/A | 3,752,000.00 | 3,165,000.00 | 2,629,000.00 | 3,029,000.00 | 3,866,000.00 | 2,718,000.00 | 2,222,000.00 | 2,225,000.00 | 3,202,000.00 | 2,558,000.00 | 2,374,000.00 | 1,755,000.00 | 1,342,000.00 |
Current Trade Receivables | N/A | 5,693,000.00 | 6,886,000.00 | 6,652,000.00 | 7,346,000.00 | 7,086,000.00 | 7,177,000.00 | 7,305,000.00 | 8,122,000.00 | 2,506,000.00 | 2,829,000.00 | 4,087,000.00 | 3,022,000.00 | 5,225,000.00 |
Current Prepayments | N/A | 958,000.00 | 930,000.00 | 1,982,000.00 | 1,196,000.00 | 809,000.00 | 1,769,000.00 | 1,075,000.00 | 1,572,000.00 | 1,018,000.00 | 1,555,000.00 | 2,280,000.00 | 1,939,000.00 | 1,648,000.00 |
Other Current Receivables | N/A | 2,290,000.00 | 577,000.00 | 1,215,000.00 | 684,000.00 | 604,000.00 | 738,000.00 | 101,440,000.00 | 1,106,000.00 | 389,000.00 | 1,769,000.00 | 589,000.00 | 786,000.00 | 1,350,000.00 |
Current Tax Assets Current | N/A | 4,129,000.00 | 5,279,000.00 | 7,003,000.00 | 8,060,000.00 | 10,554,000.00 | 6,272,000.00 | 7,540,000.00 | 9,797,000.00 | 11,843,000.00 | 6,444,000.00 | 7,395,000.00 | 8,968,000.00 | 4,516,000.00 |
Cash and cash equivalents | 18,122,000.00 | 24,510,000.00 | 107,943,000.00 | 86,715,000.00 | 74,979,000.00 | 59,554,000.00 | 45,523,000.00 | 27,016,000.00 | 107,862,000.00 | 98,946,000.00 | 81,792,000.00 | 57,732,000.00 | 85,374,000.00 | 69,943,000.00 |
Cash | N/A | 24,510,000.00 | 107,943,000.00 | 86,715,000.00 | N/A | 59,554,000.00 | 45,523,000.00 | 27,016,000.00 | N/A | N/A | N/A | N/A | N/A | N/A |
Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 4,481,000.00 | 4,402,000.00 | 4,408,000.00 | 3,166,000.00 |
Equity And Liabilities | N/A | 58,053,000.00 | 140,286,000.00 | 121,378,000.00 | 109,479,000.00 | 100,691,000.00 | 81,255,000.00 | 163,257,000.00 | 146,878,000.00 | 133,571,000.00 | 108,640,000.00 | 85,295,000.00 | 112,084,000.00 | 97,900,000.00 |
Equity | 25,322,000.00 | 18,966,000.00 | 100,912,000.00 | 86,738,000.00 | 76,474,000.00 | 62,821,000.00 | 45,964,000.00 | 123,907,000.00 | 107,917,000.00 | 91,080,000.00 | 70,221,000.00 | 55,213,000.00 | 81,056,000.00 | 70,765,000.00 |
Issued Capital | N/A | 199,936,000.00 | 266,582,000.00 | 266,582,000.00 | 267,754,000.00 | 267,754,000.00 | 267,754,000.00 | 334,693,000.00 | 334,693,000.00 | 334,693,000.00 | 334,693,000.00 | 334,693,000.00 | 379,670,000.00 | 379,670,000.00 |
Retained Earnings | N/A | -181,491,000.00 | -166,770,000.00 | -180,715,000.00 | -192,177,000.00 | -205,296,000.00 | -221,671,000.00 | -210,617,000.00 | -225,898,000.00 | -241,314,000.00 | -264,238,000.00 | -279,233,000.00 | -298,492,000.00 | -308,071,000.00 |
Treasury Shares | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | N/A | 39,087,000.00 | 39,374,000.00 | 34,640,000.00 | 33,005,000.00 | 37,870,000.00 | 35,291,000.00 | 39,350,000.00 | 38,961,000.00 | 42,491,000.00 | 38,419,000.00 | 30,082,000.00 | 31,028,000.00 | 27,135,000.00 |
Noncurrent Liabilities | N/A | 10,275,000.00 | 8,444,000.00 | 8,297,000.00 | 8,044,000.00 | 11,205,000.00 | 10,501,000.00 | 9,720,000.00 | 9,393,000.00 | 9,157,000.00 | 7,448,000.00 | 6,566,000.00 | 5,635,000.00 | 4,889,000.00 |
Other Noncurrent Liabilities | N/A | 1,553,000.00 | 452,000.00 | 301,000.00 | 301,000.00 | 301,000.00 | 301,000.00 | 137,000.00 | 137,000.00 | 137,000.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Liabilities | N/A | 28,812,000.00 | 30,930,000.00 | 26,343,000.00 | 24,961,000.00 | 26,665,000.00 | 24,790,000.00 | 29,630,000.00 | 29,568,000.00 | 33,334,000.00 | 30,971,000.00 | 23,516,000.00 | 25,393,000.00 | 22,246,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 2,204,000.00 | 4,636,000.00 | 2,490,000.00 | 3,584,000.00 | 5,409,000.00 | 4,260,000.00 | 7,233,000.00 | 6,008,000.00 | 3,978,000.00 | 10,457,000.00 | 5,256,000.00 | 5,742,000.00 | 2,480,000.00 |
Accruals Classified As Current | N/A | N/A | N/A | N/A | N/A | N/A | 17,471,000.00 | 19,241,000.00 | 20,327,000.00 | 26,004,000.00 | 17,237,000.00 | 15,011,000.00 | 16,253,000.00 | 16,248,000.00 |
Other Current Payables | N/A | 23,167,000.00 | 23,389,000.00 | 21,346,000.00 | 19,571,000.00 | 18,159,000.00 | 17,471,000.00 | 19,241,000.00 | 20,327,000.00 | 26,004,000.00 | N/A | N/A | N/A | N/A |
Current Tax Liabilities Current | N/A | 93,000.00 | 77,000.00 | 81,000.00 | 80,000.00 | 82,000.00 | 84,000.00 | 86,000.00 | 0.00 | 97,000.00 | 80,000.00 | 78,000.00 | 78,000.00 | 80,000.00 |
Line item in (dkk) | 01.01.2020/ 01.10.2020 |
01.01.2020/ 01.01.2021 |
01.07.2020/ 01.10.2020 |
01.01.2021/ 01.04.2021 |
01.01.2021/ 01.07.2021 |
01.01.2021/ 01.10.2021 |
01.01.2021/ 01.01.2022 |
01.04.2021/ 01.07.2021 |
01.07.2021/ 01.10.2021 |
01.10.2021/ 01.01.2022 |
01.01.2022/ 01.04.2022 |
01.01.2022/ 01.07.2022 |
01.01.2022/ 01.10.2022 |
01.01.2022/ 01.01.2023 |
01.04.2022/ 01.07.2022 |
01.07.2022/ 01.10.2022 |
01.10.2022/ 01.01.2023 |
01.01.2023/ 01.04.2023 |
01.01.2023/ 01.07.2023 |
01.01.2023/ 01.10.2023 |
01.04.2023/ 01.07.2023 |
01.07.2023/ 01.10.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15,672,000.00 | 23,204,000.00 | 4,742,000.00 | 5,577,000.00 | 12,153,000.00 | 17,447,000.00 | 24,254,000.00 | 6,576,000.00 | 5,294,000.00 | N/A | 6,502,000.00 | 15,008,000.00 | 20,279,000.00 | 28,969,000.00 | 8,506,000.00 | 5,271,000.00 | N/A | 8,041,000.00 | 15,789,000.00 | 24,398,000.00 | 7,748,000.00 | 8,609,000.00 |
Profit Loss From Operating Activities | -50,757,000.00 | -63,590,000.00 | -17,705,000.00 | -18,178,000.00 | -32,694,000.00 | -47,170,000.00 | -65,255,000.00 | -14,516,000.00 | -14,476,000.00 | N/A | -18,218,000.00 | -38,355,000.00 | -58,324,000.00 | -81,527,000.00 | -20,137,000.00 | -19,969,000.00 | N/A | -16,950,000.00 | -37,805,000.00 | -49,505,000.00 | -20,855,000.00 | -11,700,000.00 |
Finance Income | 4,000.00 | 4,000.00 | 0.00 | 1,334,000.00 | 922,000.00 | 1,765,000.00 | 2,461,000.00 | -412,000.00 | 843,000.00 | N/A | 185,000.00 | 1,164,000.00 | 2,876,000.00 | 1,185,000.00 | 979,000.00 | 1,712,000.00 | N/A | 22,000.00 | 57,000.00 | 1,213,000.00 | 35,000.00 | 1,156,000.00 |
Finance Costs | 1,512,000.00 | 3,248,000.00 | 969,000.00 | 244,000.00 | 466,000.00 | 692,000.00 | 1,046,000.00 | 222,000.00 | 226,000.00 | N/A | 249,000.00 | 475,000.00 | 995,000.00 | 1,205,000.00 | 226,000.00 | 520,000.00 | N/A | 273,000.00 | 419,000.00 | 493,000.00 | 146,000.00 | 74,000.00 |
Profit Loss Before Tax | -52,265,000.00 | -66,834,000.00 | -18,674,000.00 | -17,088,000.00 | -32,238,000.00 | -46,097,000.00 | -63,840,000.00 | -15,150,000.00 | -13,859,000.00 | N/A | -18,282,000.00 | -37,666,000.00 | -56,443,000.00 | -81,547,000.00 | -19,384,000.00 | -18,777,000.00 | N/A | -17,201,000.00 | -38,167,000.00 | -48,785,000.00 | -20,966,000.00 | -10,618,000.00 |
Income Tax Expense Continuing Operations | -4,123,000.00 | -5,272,000.00 | -1,325,000.00 | 1,724,000.00 | -3,251,000.00 | -5,726,000.00 | -6,727,000.00 | -1,527,000.00 | -2,475,000.00 | N/A | 1,252,000.00 | -3,545,000.00 | -5,445,000.00 | -5,624,000.00 | -2,293,000.00 | -1,900,000.00 | N/A | -1,141,000.00 | -2,458,000.00 | -3,478,000.00 | -1,317,000.00 | -1,020,000.00 |
Profit (loss) | -48,142,000.00 | -61,562,000.00 | -17,349,000.00 | -15,364,000.00 | -28,987,000.00 | -40,371,000.00 | -57,113,000.00 | -13,623,000.00 | -11,384,000.00 | -16,742,000.00 | -17,030,000.00 | -34,121,000.00 | -50,998,000.00 | -75,923,000.00 | -17,091,000.00 | -16,877,000.00 | -24,925,000.00 | -16,060,000.00 | -35,709,000.00 | -45,307,000.00 | -19,649,000.00 | -9,598,000.00 |
Line item in (dkk) | 01.01.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 | 01.10.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit (loss) | N/A | -17,349,000.00 | -61,562,000.00 | -15,364,000.00 | -13,623,000.00 | -11,384,000.00 | -16,742,000.00 | -17,030,000.00 | -17,091,000.00 | -16,877,000.00 | -24,925,000.00 | -16,060,000.00 | -19,649,000.00 | -9,598,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | N/A | N/A | N/A | 136,000.00 | -701,000.00 | 616,000.00 | 496,000.00 | 493,000.00 | -484,000.00 | 434,000.00 | 184,000.00 | 706,000.00 | 1,313,000.00 |
Adjustments For Increase Decrease In Trade Account Payable | N/A | N/A | N/A | N/A | -1,052,000.00 | 773,000.00 | -376,000.00 | 1,737,000.00 | 1,748,000.00 | -282,000.00 | 6,197,000.00 | -5,201,000.00 | -4,715,000.00 | -7,977,000.00 |
Adjustments For Increase Decrease In Other Operating Payables | N/A | N/A | N/A | N/A | -3,818,000.00 | N/A | -5,918,000.00 | N/A | 2,856,000.00 | N/A | N/A | N/A | N/A | N/A |
Adjustments For Depreciation And Amortisation Expense | N/A | N/A | N/A | N/A | 2,084,000.00 | 3,264,000.00 | 4,329,000.00 | 1,062,000.00 | 2,163,000.00 | 3,270,000.00 | 3,966,000.00 | 687,000.00 | 1,364,000.00 | 2,037,000.00 |
Adjustments For Sharebased Payments | N/A | 3,299,000.00 | 5,316,000.00 | 1,419,000.00 | 414,000.00 | -1,321,000.00 | -966,000.00 | 1,909,000.00 | 3,802,000.00 | 5,574,000.00 | 7,556,000.00 | 1,065,000.00 | 1,966,000.00 | 2,027,000.00 |
Other Adjustments For Noncash Items | N/A | 866,000.00 | 915,000.00 | 0.00 | 284,000.00 | 0.00 | 311,000.00 | 0.00 | 0.00 | 0.00 | -945,000.00 | 39,000.00 | 117,000.00 | -271,000.00 |
Cash Flows From Used In Operations | N/A | -31,945,000.00 | -38,353,000.00 | -20,827,000.00 | -35,479,000.00 | -50,491,000.00 | -69,030,000.00 | -16,427,000.00 | -28,409,000.00 | -35,942,000.00 | -57,768,000.00 | -26,077,000.00 | -38,892,000.00 | -53,419,000.00 |
Other Inflows Outflows Of Cash Classified As Operating Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | N/A | -1,849,000.00 | -2,747,000.00 |
Cash Flows From Used In Operating Activities | N/A | -27,506,000.00 | -35,616,000.00 | -21,069,000.00 | -35,120,000.00 | -49,850,000.00 | -64,577,000.00 | -16,625,000.00 | -28,742,000.00 | -36,111,000.00 | -52,485,000.00 | -26,328,000.00 | -39,254,000.00 | -52,791,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 1,046,000.00 | 1,315,000.00 | 53,000.00 | 270,000.00 | 148,000.00 | 130,000.00 | 407,000.00 | 407,000.00 | 407,000.00 | 407,000.00 | 0.00 | 0.00 | 0.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 25,000.00 | 184,000.00 | 196,000.00 | 148,000.00 | 270,000.00 | 259,000.00 | 65,000.00 | 65,000.00 | 65,000.00 | 64,000.00 | 0.00 | 0.00 | 0.00 |
Purchase Of Other Longterm Assets Classified As Investing Activities | N/A | 22,000.00 | 22,000.00 | N/A | N/A | 23,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Flows From Used In Investing Activities | N/A | -1,093,000.00 | -1,521,000.00 | -249,000.00 | -441,000.00 | -441,000.00 | -412,000.00 | -472,000.00 | -503,000.00 | -503,000.00 | -503,000.00 | -31,000.00 | -31,000.00 | -961,000.00 |
Proceeds From Issuing Shares | N/A | 39,987,000.00 | 146,620,000.00 | N/A | N/A | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 2,101,000.00 | 2,859,000.00 | 808,000.00 | 1,635,000.00 | 2,368,000.00 | 3,099,000.00 | 669,000.00 | 1,513,000.00 | 2,773,000.00 | 3,737,000.00 | 923,000.00 | 1,841,000.00 | 2,757,000.00 |
Cash Flows From Used In Financing Activities | N/A | 35,027,000.00 | 127,035,000.00 | -959,000.00 | 2,552,000.00 | 1,819,000.00 | 1,101,000.00 | -1,433,000.00 | 91,354,000.00 | 89,783,000.00 | 88,699,000.00 | 2,257,000.00 | 42,729,000.00 | 41,771,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 6,428,000.00 | 89,898,000.00 | -22,277,000.00 | -33,009,000.00 | -48,472,000.00 | -63,888,000.00 | -18,530,000.00 | 62,109,000.00 | 53,169,000.00 | 35,711,000.00 | -24,102,000.00 | 3,443,000.00 | -11,980,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -40,000.00 | -77,000.00 | 1,049,000.00 | 45,000.00 | 83,000.00 | 1,468,000.00 | 23,000.00 | 230,000.00 | 254,000.00 | 558,000.00 | 42,000.00 | 139,000.00 | 131,000.00 |
Cash and cash equivalents | 18,122,000.00 | 24,510,000.00 | 107,943,000.00 | 86,715,000.00 | 74,979,000.00 | 59,554,000.00 | 45,523,000.00 | 27,016,000.00 | 107,862,000.00 | 98,946,000.00 | 81,792,000.00 | 57,732,000.00 | 85,374,000.00 | 69,943,000.00 |
Please note that some sums might not add up.
DK0011048619
LEI5299004SWFL5JAN4W830
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.